{
    "clinical_study": {
        "@rank": "121003", 
        "arm_group": [
            {
                "arm_group_label": "High intensity aerobic interval training", 
                "arm_group_type": "Experimental", 
                "description": "Older adults will complete 8 weeks of high intensity aerobic interval exercise training."
            }, 
            {
                "arm_group_label": "Continuous moderate intensity exercise", 
                "arm_group_type": "Experimental", 
                "description": "Older adults will complete 8 weeks of continuous moderate intensity exercise training."
            }, 
            {
                "arm_group_label": "Non-exercise control group", 
                "arm_group_type": "No Intervention", 
                "description": "Older adults assigned to the non-exercise control group will maintain their normal lifestyle for 8 weeks."
            }, 
            {
                "arm_group_label": "Young Healthy controls", 
                "arm_group_type": "No Intervention", 
                "description": "Young healthy subjects will be assigned to the healthy control group and will undergo baseline measures only."
            }
        ], 
        "brief_summary": {
            "textblock": "Study objectives:\n\n        1. To compare cardiovascular function in older compared to young healthy adults.\n\n        2. To compare the effect of 8 weeks of aerobic interval training vs. continuous moderate\n           exercise on cardiovascular function in healthy older adults.\n\n      Hypotheses:\n\n        1. Compared to young adults, older adults will have lower cardiovascular function.\n\n        2. Compared to continuous moderate intensity exercise training, interval training will be\n           more effective in improving cardiovascular function in older adults."
        }, 
        "brief_title": "Effect of Aerobic Interval Training on Cardiovascular Function in Aging", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Aging", 
        "detailed_description": {
            "textblock": "Cardiovascular function will be measured at baseline in older healthy adults and young\n      healthy controls. Older adults will be randomized to the aerobic interval training group,\n      continuous moderate exercise group or non-exercise control group. At the end of the 8-week\n      exercise intervention, baseline measures will be repeated in the older adults."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria for older adults:\n\n          -  Healthy men and women 55 to 79 years of age\n\n          -  Sedentary or minimally physically active for at least the prior 1 year.\n\n          -  Women will be premenopausal or postmenopausal (either natural or surgical) defined as\n             a cessation of menses for at least 2 years.\n\n          -  Premenopausal women will be eumenorrheic and will be studied during the early\n             follicular phase (days 1 through 6) of the menstrual cycle.\n\n          -  Able to give consent.\n\n        Inclusion Criteria for young adults:\n\n          -  Healthy men and women 18 to 35 years of age\n\n          -  Sedentary or minimally physically active for at least the prior 1 year.\n\n          -  Women will be premenopausal, eumenorrheic and will be studied during the early\n             follicular phase (days 1 through 6) of the menstrual cycle.\n\n          -  Able to give consent.\n\n        Exclusion Criteria:\n\n          -  history of diabetes\n\n          -  history of any relevant cardiovascular diseases (myocardial infarction, angina\n             pectoris, history of coronary artery bypass surgery or angioplasty, congestive heart\n             failure, or arrhythmia)\n\n          -  hypertension (\u2265160 mmHg systolic or \u2265100 mmHg diastolic)\n\n          -  history of renal impairment\n\n          -  history of gout or hyperuricemia\n\n          -  history of hepatic disease or infection with hepatitis B, C\n\n          -  history of seizures, or other relevant on-going or recurrent illness\n\n          -  recent (within 3 months) or recurrent hospitalizations\n\n          -  use of tobacco products\n\n          -  >5 % weight change in the prior 6 months.\n\n          -  current intake of medications that may affect study results\n\n          -  participation in regular aerobic exercise training (>30 minutes,\n\n               -  3 times/wk in the past year).\n\n          -  premenopausal women taking oral contraceptives and postmenopausal women taking\n             hormone replacement therapy.\n\n          -  pregnancy (positive urine pregnancy test) or lactation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "79 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "125", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01883271", 
            "org_study_id": "551-2012"
        }, 
        "intervention": [
            {
                "arm_group_label": "High intensity aerobic interval training", 
                "description": "Supervised aerobic interval training will be performed on bicycles 4 times per week for 8 weeks. Each training session will last 40 minutes and will consist of 10-minute warm up at 70% of maximal heart rate (HRmax), four 4-minute intervals at 90% of HRmax with 3-min active recovery at 70% of HRmax and 5-minute cool down at 70% of HRmax.", 
                "intervention_name": "High intensity aerobic interval training", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Continuous moderate intensity exercise", 
                "description": "Supervised exercise training will be performed on bicycles 4 times per week for 8 weeks. Each training session will last 47 minutes and will consist of continuous moderate intensity cycling at 70% of HRmax.", 
                "intervention_name": "Continuous moderate intensity exercise", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 7, 2014", 
        "location": {
            "contact": {
                "email": "ddchristou@ufl.edu", 
                "last_name": "Demetra D Christou, Ph.D", 
                "phone": "352-294-1715"
            }, 
            "facility": {
                "address": {
                    "city": "Gainesville", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "32611"
                }, 
                "name": "University of Florida"
            }, 
            "investigator": {
                "last_name": "Demetra D Christou, Ph.D", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Effect of Aerobic Interval vs. Continuous Exercise Training on Cardiovascular Function in Aging", 
        "overall_contact": {
            "email": "ddchristou@ufl.edu", 
            "last_name": "Demetra D Christou, Ph.D", 
            "phone": "352-294-1715"
        }, 
        "overall_official": {
            "affiliation": "University of Florida", 
            "last_name": "Demetra D Christou, Ph.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Brachial flow-mediated dilation using ultrasonography", 
            "measure": "Change in vascular endothelial function", 
            "safety_issue": "No", 
            "time_frame": "At baseline and after 8 weeks of exercise training"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01883271"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Blood and cellular markers of oxidative stress and inflammation", 
                "measure": "Change in factors related with endothelial function", 
                "safety_issue": "No", 
                "time_frame": "At baseline and after 8 weeks of exercise training"
            }, 
            {
                "description": "Arterial stiffness and wave reflection will be measured using the SphygmoCor device", 
                "measure": "Change in arterial stiffness", 
                "safety_issue": "No", 
                "time_frame": "At baseline and after 8 weeks of exercise training"
            }, 
            {
                "description": "Left ventricular systolic and diastolic function will be measured using echocardiography", 
                "measure": "Change in cardiac function", 
                "safety_issue": "No", 
                "time_frame": "At baseline and after 8 weeks of exercise training"
            }, 
            {
                "description": "Maximal oxygen consumption will be measured using online computer-assisted open-circuit spirometry during incremental treadmill exercise", 
                "measure": "Change in maximal oxygen consumption", 
                "safety_issue": "No", 
                "time_frame": "At baseline and after 8 weeks of exercise training"
            }
        ], 
        "source": "University of Florida", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Florida", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor)", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}